grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

October 24, 2017

Omnicell Announces Annual Innovation Day For Analysts And Investors

Download PDF

MOUNTAIN VIEW, Calif., Oct. 24, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management and supply chain solutions to health systems, today announced they will host an innovation day for analysts and investors at the Annual ASHP Midyear Meeting on December 4, 2017.

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Peter Kuipers, executive vice president & CFO

Date: Monday, December 4, 2017
Time: 9:00 a.m. - 11:00 a.m. ET
Location: Orange County Convention Center West Concourse, Orlando, FL - Booth #1101


9:00 a.m. - Product Demonstration and Innovation Review for Analysts and Investors attending in person at Booth #1101.

10:00 a.m. - Innovation Presentation and Q&A. For call in and replay details please see below:

The innovation presentation and Q&A can be monitored by dialing 1-844-358-6756 within the U.S. or 1-216-562-0399 for all other locations. The Conference ID # is 4289338.  The webcast can be accessed at:  A replay will be available starting at 1:00 p.m. ET on December 4, 2017 through 11:59 p.m. ET on December 14, 2017. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 4289338.

For Investors interested in attending this event in person, please email Michelle Smith at

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.

The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. These medication adherence solutions are used by over 17,000 institutional and retail pharmacies in North America and the United Kingdom. These pharmacies are served via the Company's sales channels and our solutions enable them to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit



View original content with multimedia:

SOURCE Omnicell, Inc.

News Provided by Acquire Media